Targeting Insulin Receptor with a Novel Internalizing Aptamer
Nucleic acid-based aptamers are emerging as therapeutic antagonists of disease-associated proteins such as receptor tyrosine kinases. They are selected by an in vitro combinatorial chemistry approach, named Systematic Evolution of Ligands by Exponential enrichment (SELEX), and thanks to their small...
Saved in:
Main Authors: | Margherita Iaboni (Author), Raffaela Fontanella (Author), Anna Rienzo (Author), Maria Capuozzo (Author), Silvia Nuzzo (Author), Gianluca Santamaria (Author), Silvia Catuogno (Author), Gerolama Condorelli (Author), Vittorio de Franciscis (Author), Carla Lucia Esposito (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL
by: Margherita Iaboni, et al.
Published: (2016) -
Identification of a novel RNA aptamer that selectively targets breast cancer exosomes
by: Carla Lucia Esposito, et al.
Published: (2021) -
Aptamer-Mediated Targeted Delivery of Therapeutics: An Update
by: Silvia Catuogno, et al.
Published: (2016) -
An Anti-BCMA RNA Aptamer for miRNA Intracellular Delivery
by: Silvia Catuogno, et al.
Published: (2019) -
STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma
by: Carla Lucia Esposito, et al.
Published: (2018)